The court, which had earlier issued open-ended non-bailable warrants against pharma firm#39;s directors, including Chetan Jayantilal Sandesara and Nitin Jayantilal Sandesara, put up the charge sheet, filed by ED#39;s special public prosecutor Nitesh Rana, for consideration on October 3.ED files supplementary charge sheet in Sterling Biotech case
The court, which had earlier issued open-ended non-bailable warrants against pharma firm#39;s directors, including Chetan Jayantilal Sandesara and Nitin Jayantilal Sandesara, put up the charge sheet, filed by ED#39;s special public prosecutor Nitesh Rana, for consideration on October 3.
Subscribe to:
Post Comments (Atom)
-
Huawei faces international scrutiny over its ties with the Chinese government and suspicion that Beijing could use Huawei#39;s technology f...
-
In July, HCL Technologies had announced a Rs 4,000 crore buyback programme for FY19 at a price of Rs 1,100 per equity share.
No comments:
Post a Comment